KBT Blend: BPC-157/TB-500/KPV

60mg per vial

PeptidesPartnersKBT Blend: BPC-157/TB-500/KPV60mgRESEARCH USE ONLY

Available packs

2 vials120mg5 vials300mg10 vials600mg

KBT Blend: BPC-157/TB-500/KPV

$159 - $599

Buy KBT Blend: BPC-157/TB-500/KPV (60mg vials) from Peptides Partners

Laboratories and independent academic institutions seeking advanced multi-peptide formulations can buy KBT Blend: BPC-157/TB-500/KPV directly from Peptides Partners. Formulated as a targeted tri-peptide complex within our cellular repair catalog, this research preparation consolidates three distinct biological signaling molecules into a unified, lyophilized matrix. Each vial provides a total mass of 60mg of high-grade peptide material, structured specifically to allow researchers to investigate multi-pathway tissue remodeling, cytoskeletal actin reorganization, and inflammatory signaling attenuation without managing separate reconstitutions.

At Peptides Partners, we recognize the stringent requirements of contemporary biomedical assays. When you procure research peptides from our catalog, your laboratory receives compounds synthesized using established solid-phase peptide synthesis (SPPS) protocols, protected by controlled atmospheric lyophilization to preserve structural fidelity. The KBT Blend offers an exceptional platform for comparative in vitro studies, histological tissue cultures, and complex cell-signaling assays designed to analyze cellular migration, cytoprotective responses, and extracellular matrix deposition.

Our global distribution infrastructure ensures that when you buy KBT Blend: BPC-157/TB-500/KPV, the material is dispatched under climate-controlled conditions to protect peptide chain stability from thermal degradation. Whether your research group is running baseline microplate assays, exploring peptide synergy in fibroblast dynamics, or conducting automated cellular imaging, Peptides Partners supplies the reliable, high-integrity reagents necessary to generate reproducible, publishable laboratory data.

What is KBT Blend: BPC-157/TB-500/KPV?

The KBT Blend is a composite research peptide formulation containing three distinct peptide sequences: BPC-157, TB-500, and KPV. Classified under the research domain of cellular repair and cytoprotection, this blend facilitates the simultaneous exploration of multiple biochemical cascades that govern cell survival, tissue architecture reconstruction, and molecular-level inflammatory mediation.

The first component, BPC-157 (Body Protection Compound-157), is a synthetic 15-amino acid pentadecapeptide derived from a naturally occurring protective peptide isolated from gastric secretions. Its primary sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. In scientific literature, BPC-157 is widely studied for its unusual stability in biological fluids and its regulatory interaction with growth factor expression, nitric oxide synthesis pathways, and focal adhesion dynamics.

The second constituent, TB-500, is a synthetic derivative representing the active bioactive region of Thymosin Beta-4 (Tβ4), a 43-amino acid ubiquitous protein. The sequence of TB-500 corresponds to the primary actin-binding domain (Ac-LKKTETQ). In cellular environments, this domain acts as a major G-actin sequestering molecule, regulating the dynamic equilibrium between globular and filamentous actin, which forms the structural basis of cell motility, cytoskeletal restructuring, and tissue morphogenesis.

The third constituent, KPV, is a tripeptide corresponding to the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). Composed of the amino acids Lysine-Proline-Valine (Lys-Pro-Val), KPV functions as a biologically active signaling fragment that does not activate melanocortin 1 receptors (MC1R) associated with pigmentary changes, but rather participates in intracellular transport mechanisms through the PepT1 transporter to alter nuclear transcription factors.

Because each of these individual sequences operates through entirely distinct cell surface receptors and intracellular pathways, formulating them into a 60mg composite vial enables research teams to observe cellular behavior under concurrent stimulation, mirroring the multifaceted signaling environments found in native tissue repair cascades.

Research effects studied

In preclinical cell models and animal-based tissue regeneration experiments, each peptide within the KBT Blend has generated significant scientific literature regarding its discrete and potentially complementary cellular mechanisms:

Vascular and Endothelial Signaling (BPC-157): Preclinical models have examined BPC-157 for its capacity to influence the early growth response 1 (Egr-1) gene, vascular endothelial growth factor (VEGF), and vascular endothelial growth factor receptor 2 (VEGFR2). In cell culture models utilizing human umbilical vein endothelial cells (HUVECs), BPC-157 has been observed to accelerate tube formation and promote endothelial cell migration, suggesting a direct role in pro-angiogenic signaling cascades. Furthermore, research indicates that BPC-157 modulates the nitric oxide (NO) system through endothelial nitric oxide synthase (eNOS) activation, influencing cellular survival during ischemic injury models.
Fibroblast Migration and ECM Synthesis (BPC-157): Research investigating tendon and ligament explants has demonstrated that BPC-157 promotes the phosphorylation of focal adhesion kinase (FAK) and paxillin. This biochemical activation correlates with enhanced fibroblast outgrowth, elevated collagen type I transcription, and faster repopulation of scratch-wound assays in laboratory settings.
Actin Polymerization and Cytoskeletal Dynamics (TB-500): As an actin-sequestering peptide, TB-500 has been widely evaluated for its capacity to modulate cytoskeletal plasticity. Preclinical studies indicate that by sequestering free G-actin, the peptide prevents premature filament aggregation, maintaining an intracellular pool of actin monomers ready for rapid mobilization. This allows cells—such as keratinocytes, fibroblasts, and endothelial cells—to exhibit increased lamellipodia formation and cellular motility across extracellular matrices during wound closure simulations.
Matrix Metalloproteinase Regulation (TB-500): Scientific investigations have focused on the role of TB-500 in upregulating matrix metalloproteinases (MMPs), specifically MMP-2 and MMP-9. By modifying local extracellular matrix remodeling, TB-500 appears in research to facilitate the clearance of damaged structural proteins, supporting organized tissue deposition rather than disorganized fibrotic scarring in experimental models.
Nuclear Factor-Kappa B (NF-κB) Attenuation (KPV): The tripeptide KPV has been extensively investigated for its role in suppressing the translocation of the p65 subunit of NF-κB into the cellular nucleus. In preclinical mucosal and dermal inflammatory models, the uptake of KPV via the solute carrier family 15 member 1 (PepT1) transporter leads to a downstream downregulation of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6).
Antimicrobial and Cytoprotective Pathways (KPV): In vitro studies have explored KPV for direct cytoprotective effects against microbial disruption in epithelial cell layers. Researchers have reported that KPV can alter cell membrane permeability in specific bacterial strains while simultaneously stabilizing tight junction proteins, such as zonula occludens-1 (ZO-1) and occludin, in stressed epithelial monolayers.
Combined Cellular Repair Synergy: The core scientific interest in the KBT Blend centers on whether the simultaneous presence of an angiogenic and focal-adhesion promoter (BPC-157), a cell migration and actin dynamics driver (TB-500), and a transcription-level inflammatory suppressor (KPV) creates an additive or synergistic microenvironment for tissue repair studies that exceeds the performance of any single isolate.

How to use in the laboratory

The KBT Blend: BPC-157/TB-500/KPV (60mg) is strictly formulated and provided as a lyophilized powder for in vitro experimentation, structural research, and authorized preclinical laboratory methodologies. This compound is not intended for human consumption, therapeutic use, or medical administration. Standard operating procedures for laboratory reconstitution and sample handling must be adhered to at all times.

To prepare the peptide for laboratory assays, reconstitution should be carried out using an appropriate sterile, analytical-grade diluent, such as sterile Bacteriostatic Water for research or sterile normal saline (0.9% sodium chloride for injection, laboratory grade), depending on the requirements of your analytical system or cell culture medium. Prior to diluent introduction, ensure both the vial and the solvent have reached room temperature to prevent thermal shock to the lyophilized matrix.

Aseptic techniques must be maintained throughout the procedure, ideally within an ISO-certified laminar flow hood or biological safety cabinet. Swab the rubber septum of the vial with a 70% isopropyl alcohol wipe and allow it to dry completely. Introduce the diluent slowly by directing the needle toward the internal glass wall of the vial. Allowing the liquid to run smoothly down the glass prevents violent mechanical impact, which can break fragile peptide bonds.

Do not vortex or vigorously agitate the vial. Mix the solution by gently rotating or swirling the vial between your fingers until all lyophilized cake is fully dissolved into a transparent solution. Once fully dissolved, precise aliquots should be prepared immediately using sterile microcentrifuge tubes to prevent cross-contamination and eliminate repeated thermal fluctuations.

Accurate laboratory record-keeping is critical. Document the exact volume of diluent added, calculate the resulting working concentration (e.g., mass per unit volume across the 60mg total peptide content), and label each aliquot tube with the batch number, reconstitution date, and calculated concentration. Maintain detailed logs within your electronic laboratory notebook (ELN) tracking date of reconstitution, solvent lot number, storage coordinates, and assay parameters.

Pack sizes and price per mg

Peptides Partners provides tiered volume options to accommodate various research project scopes, ranging from small-scale exploratory experiments to high-throughput, multi-well cell screening programs. Each pack contains 60mg lyophilized vials of KBT Blend, offering exceptional value and reduced per-milligram expenditure for higher-volume orders.

Pack Size	Total Milligrams	Price (USD)	Price per Milligram (Approx.)
2 vials x 60mg	120 mg	$159	$1.33 / mg
5 vials x 60mg	300 mg	$349	$1.16 / mg
10 vials x 60mg	600 mg	$599	$1.00 / mg

Investigators can select the configuration that best matches their consumption cycle, ensuring that reconstituted material is utilized within optimal stability timeframes while minimizing overall experimental cost per milligram.

Storage and handling

Maintaining the structural stability of peptide sequences requires precise environmental controls. In its lyophilized form, the KBT Blend: BPC-157/TB-500/KPV exhibits high chemical resilience when stored under proper conditions:

Lyophilized Storage (Long-Term): Keep sealed vials stored at -20°C for up to 24 months. For extended multi-year preservation, storage at -80°C in an ultra-low temperature freezer is recommended to completely halt hydrolytic and oxidative degradation pathways.
Lyophilized Storage (Short-Term): Unopened vials can be maintained under refrigeration at 2°C to 8°C for up to 90 days without measurable degradation, provided the desiccated seal remains intact.
Light and Humidity Protection: Protect vials from direct ultraviolet light, artificial high-intensity radiation, and ambient humidity. Always store vials within light-blocking outer packaging or dedicated cryogenic boxes.
Reconstituted Storage: Following reconstitution with bacteriostatic or sterile diluents, the solution should be immediately refrigerated at 2°C to 8°C and utilized within 21 to 28 days for optimal assay fidelity.
Aliquoting and Freeze-Thaw Prevention: If the reconstituted solution is intended for longitudinal experiments spanning several months, divide the liquid into single-use aliquots and store them at -20°C or -80°C. Do not subject reconstituted research peptides to repeated freeze-thaw cycles, as crystal formation mechanically shears tertiary peptide bonds and precipitates peptide aggregates out of solution.

Quality and documentation

Peptides Partners ensures that every batch of KBT Blend undergoes rigorous analytical validation to verify chemical identity, sequence fidelity, and chemical consistency. We utilize state-of-the-art solid-phase synthesis techniques, ensuring exact stoichiometric control over the assembly of each component peptide.

Quality confirmation is conducted through standard analytical testing methodologies, including High-Performance Liquid Chromatography (HPLC) to verify chromatographic profile and Mass Spectrometry (MS) to confirm precise molecular weights for each individual constituent peptide: BPC-157 (MW: 1419.53 g/mol), TB-500 (MW: 4963.5 g/mol as full Tβ4 or 889.0 g/mol for the active Ac-LKKTETQ core), and KPV (MW: 384.48 g/mol). Batch-specific documentation and analytical data are systematically cataloged to ensure full scientific traceability, reproducibility across independent trials, and conformity to analytical laboratory standards.

Frequently asked questions

What is the composition and theoretical premise of the KBT Blend?

The KBT Blend combines BPC-157, TB-500, and KPV into a single 60mg matrix. The scientific premise of this formulation is to offer an integrated tool for cellular repair research. Rather than evaluating individual pathways in isolation, researchers can use this composite blend to observe simultaneous intracellular signaling—specifically targeting the concurrent stimulation of focal adhesion kinase and angiogenesis (BPC-157), cytoskeletal actin rearrangement and cell motility (TB-500), and NF-κB transcription factor inhibition (KPV).

What diluent should be used to reconstitute KBT Blend in the laboratory?

Reconstitution generally depends on the nature of your downstream assay. For non-cellular chemical analyses or standard storage, sterile Bacteriostatic Water (containing 0.9% benzyl alcohol) is typically preferred due to its ability to prevent bacterial proliferation over extended handling windows. If the peptide is intended for immediate introduction into live cell cultures or in vitro bioassays sensitive to preservative agents, sterile 0.9% sodium chloride or sterile molecular-biology-grade water should be utilized instead.

How does KPV function differently from full-sequence alpha-MSH?

Alpha-melanocyte-stimulating hormone (α-MSH) is a 13-amino acid tridecapeptide that activates multiple melanocortin receptor subtypes, including MC1R, which modulates pigment production. KPV is the terminal tripeptide fragment (Lys-Pro-Val) of α-MSH. Research demonstrates that KPV exerts anti-inflammatory signaling primarily through cellular internalization via the PepT1 transporter and subsequent inhibition of the NF-κB pathway, without binding significantly to MC1R. This makes it an ideal isolate for researchers studying inflammatory signaling pathways independently of melanogenic receptor interference.

Can KBT Blend be stored at room temperature once reconstituted?

No. Reconstituted peptides in aqueous solutions are susceptible to hydrolysis, oxidation, and microbial growth at ambient room temperatures. Once diluent has been added to the KBT Blend vial, the solution must be stored under refrigeration between 2°C and 8°C if it is to be utilized within 3 to 4 weeks. For longer periods, it must be subdivided into single-use aliquots and maintained frozen at -20°C or -80°C. Room temperature exposure should be limited solely to the brief duration required for immediate pipetting and assay staging.

Related Peptides Partners research peptides

KLOW Blend: BPC-157/TB-500/GHK-Cu/KPV (80mg vials); Cagrilintide (10mg vials); Glutathione (1500mg vials).